NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02891824,ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab,https://clinicaltrials.gov/study/NCT02891824,ATALANTE,COMPLETED,"This is a phase III, randomized, double-blinded, comparative, multi-centre study to assess the efficacy of atezolizumab in combination with platinum-based chemotherapy plus bevacizumab administered concurrent to chemotherapy and in maintenance, in patients presenting epithelial ovarian cancer (including patients with primary peritoneal and / or fallopian tube adenocarcinoma) who have platinum-sensitive relapse (platinum-free interval \> 6 months).",NO,Ovarian Cancer,DRUG: atezolizumab + avastin + platinum-based chemotherapy|DRUG: placebo + avastin + platinum-based chemotherapy,"Efficacy: Progression free survival, where the date of progression is based on investigator assessment using the RECIST version 1.1, An average of 19 months","Efficacy: Overall survival (OS), To be assessed around 73 months|Efficacy: Time from date randomization to second subsequent therapy or date of death (TSST) whichever come first, To be assessed around 73 months|patient reported outcome variables, questionnaire to be completed by patients and collected frequently during the study, to be assessed 19 months|Adverse events, frequency of adverse events according to MedRA terms, to be assessed 19 months",,ARCAGY/ GINECO GROUP,Hoffmann-La Roche,FEMALE,"ADULT, OLDER_ADULT",PHASE3,614,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",GINECO-OV236b,2016-09-22,2021-10-15,2024-02-22,2016-09-08,,2025-03-25,"Krankenhaus der Barmherzigen Brüder Graz, Graz, 8020, Austria|Medical University of Graz, Graz, 8036, Austria|Medical University of Innsbruck, Innsbruck, 6020, Austria|Medical University of Vienna, Vienna, 1090, Austria|UZ Gent, Gent, 9000, Belgium|Uz Leuven, Leuven, 3000, Belgium|General University Hospital in Prague, Prague, 128 51, Czechia|ICO Paul Papin, Angers, France|Sainte-Catherine Institut du Cancer Avignon-Provence, Avignon, France|CHRU Jean Minjoz, Besançon, France|Clinique Tivoli, Bordeaux, France|Institut Bergonié, Bordeaux, France|Centre François Baclesse, Caen, France|Centre Jean Perrin, Clermont-Ferrand, France|Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France|Hôpital Michallon - Centre Hospitalier Universitaire de Grenoble, Grenoble, France|Centre Hospitalier Départemental Les Oudairies, La Roche sur Yon, France|Centre Oscar Lambret, Lille, France|Centre Léon Bérard, Lyon, France|Institut Paoli Calmettes, Marseille, France|Hôpital de Mont-de-Marsan, Mont de Marsan, France|ICM Val d'Aurelle, Montpellier, France|Centre Azuréen de Cancérologie, Mougins, France|ORACLE - Centre d'Oncologie de Gentilly, Nancy, France|Hôpital Privé du Confluent, S.A.S., Nantes, France|Centre Antoine Lacassagne, Nice, France|CHU Nîmes - Institut de Cancérologie du Gard, Nimes, France|Centre Hospitalier Régional d'Orléans, Orléans, France|Groupe Hospitalier Diaconesses-Croix Saint Simon, Paris, France|Groupe Hospitalier Saint-Joseph, Paris, France|Hôpital Cochin, Paris, France|Hôpital Européen Georges Pompidou, Paris, France|Hôpital Tenon, Paris, France|Institut Curie - Hopital Claudius Régaud, Paris, France|Centre Hospitalier Lyon Sud, Pierre Bénite, France|Centre CARIO - HPCA, Plérin, France|Hôpital de la Milétrie - Centre Hospitalier Universitaire de Poitiers - Pôle Régional de Cancérologie, Poitiers, France|Centre Eugène Marquis, Rennes, France|Hôpital René Huguenin, Institut Curie, Saint-Cloud, France|ICO Centre René Gauducheau, Saint-Herblain, France|Centre Paul Strauss, Strasbourg, France|Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France|Clinique Pasteur, Toulouse, France|Institut Claudius Regaud, Toulouse, France|ICL Institut de Cancérologie de Lorraine, Vandoeuvre Les Nancy, France|Gustave Roussy, Villejuif, France|Charité, Campus Virchow-Klinikum, Universitätsmedizin Berlin, Berlin, Germany|Universitätsklinikum Carl Gustav Carus, Dresden, Germany|Universitatsklinikum Dusseldorf, Dusseldorf, Germany|Kliniken Essen Mitte, Evang. Huyssens-Stiftung, Essen, 45136, Germany|Universitätsklinikum Essen, Essen, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Jena, Jena, Germany|Städtisches Klinikum Karlsruhe, Karlsruhe, Germany|Klinikum der Universität München - LMU, Campus Großhadern, München, Germany|Klinikum rechts der Isar, Technischen Universität München, München, Germany|Sana Klinikum Offenbach, Offenbach, Germany|Studienzentrum Onkologie Ravensburg, Ravensburg, Germany|Universitatsklinikum Tübingen, Tübingen, 72076, Germany|Universitätsklinikum Ulm, ULM, Germany|Klinikum Worms, Worms, 67550, Germany|Sharre Zedek Medical Centre, Jerusalem, Israel|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clínic Barcelona, Barcelona, 8036, Spain|Hospital San Pedro de Alcántara, Cáceres, 10003, Spain|Hospital Universitari de Girona ICO Girona (Dr. Josep Trueta), Girona, 17007, Spain|Hospital Universitario Clínico San Carlos, Madrid, 28040, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario HM Sanchinarro, Madrid, 28050, Spain|Hospital Central Universitario Virgen de la Arrixaca, Murcia, 30120, Spain|Hospital Universitario Son Espases, Palma De Mallorca, 7120, Spain|Hospital Universitario Donostia, San Sebastián, 20014, Spain|Hospital Universitario Virgen Macarena, Sevilla, 41009, Spain|Hospital Alvaro Cunqueiro, Vigo, 36312, Spain",
